Guskov AR, Gorlina NK*
Scientific, Research and Therapeutic Center “Sanos” for Non-Surgery Treatment in Urology and Andrology, Moscow, Russia; *Russian State Medical University, Moscow, Russia
Russ. J. Immunol. 1998, July 15, 3 (2), 159-166.
Previously, we had shown that patients with chronic prostatitis exhibited impassability of the prostate excretory ducts leading to the microabscesses formation in the prostate tissue. The main reasons of low efficacy of traditional antibacterial therapy were elucidated. The antibacterial therapy was shown to induce secondary immunodeficiency. Proceeding from the above, we elaborated new strategy for treating chronic prostatitis that included two main components: surgical recovery of draining from the prostate lobules (using vacuum aspiration); and complex prostatitis treatment containing obligatory immunocorrection. Ninety four patients with chronic prostatitis aged 20-55 years were examined and treated. The immunocorrection comprised three steps: (i) antioxidant therapy and initial immunocorrection accompanying surgical draining recovery; (ii) antibiotic therapy and immunocorrection; and (iii) post-treatment recovery therapy that was selected individually for each patient. The latter enabled to reveal and to treat successfully individual immune system disturbances. As a result, 97% of patients exhibited complete recovery of the prostate function and sexual activity.